Cargando…
Phosphoproteome profiling reveals critical role of JAK-STAT signaling in maintaining chemoresistance in breast cancer
Breast cancer is responsible for 25% of cancer cases and 15% of cancer death among women. Treatment is usually prolonged and hampered by the development of chemoresistance. The molecular mechanisms maintaining the chemoresistant phenotype remains, however, largely obscure. As kinase signaling in gen...
Autores principales: | Nascimento, Augusto S., Peres, Luisa L., Fari, Alessandra V.S., Milani, Renato, Silva, Rodrigo A., da Costa Fernandes, Celio Jr., Peppelenbosch, Maikel P., Ferreira-Halder, Carmen V., Zambuzzi, Willian F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5777730/ https://www.ncbi.nlm.nih.gov/pubmed/29383118 http://dx.doi.org/10.18632/oncotarget.21801 |
Ejemplares similares
-
OsteoBLAST: Computational Routine of Global Molecular Analysis Applied to Biomaterials Development
por: Ferreira, Marcel Rodrigues, et al.
Publicado: (2020) -
JAKs and STATs in chemoresistance
por: Costa-Pereira, Ana P
Publicado: (2010) -
Evidence for a Minimal Eukaryotic Phosphoproteome?
por: Diks, Sander H., et al.
Publicado: (2007) -
Violacein Induces Death of Resistant Leukaemia Cells via Kinome Reprogramming, Endoplasmic Reticulum Stress and Golgi Apparatus Collapse
por: Queiroz, Karla C. S., et al.
Publicado: (2012) -
The JAK-STAT pathway at 20
por: Darnell, Jr., James E.
Publicado: (2012)